Sponsor Pipeline

MoonLake Immunotherapeutics AG Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
1
Recruiting
5
Phase 3
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT06641089
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα…		 Trial sites expanded: 139 -> 142 locations
Active Trials by Phase
Phase 3
5
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06641089 Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα… Arthritis, Psoriatic Recruiting
NCT06768671 An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous… Hidradenitis Suppurativa Active, Not Recruiting
NCT07007637 A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous… Hidradenitis Suppurativa Enrolling by Invitation
NCT07223138 A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous… Arthritis, Psoriatic Enrolling by Invitation
NCT06641076 Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic… Arthritis, Psoriatic Active, Not Recruiting
Disease Areas
Hidradenitis Suppurativa (2)
Get alerts when MoonLake Immunotherapeutics AG's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free